0000950170-24-096399.txt : 20240813 0000950170-24-096399.hdr.sgml : 20240813 20240813170003 ACCESSION NUMBER: 0000950170-24-096399 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240809 FILED AS OF DATE: 20240813 DATE AS OF CHANGE: 20240813 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Richards C Marc CENTRAL INDEX KEY: 0001468881 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-12111 FILM NUMBER: 241202657 MAIL ADDRESS: STREET 1: 7315 WISCONSIN AVENUE STREET 2: SUITE 250-W CITY: BETHESDA STATE: MD ZIP: 20814 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Pediatrix Medical Group, Inc. CENTRAL INDEX KEY: 0000893949 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HOSPITALS [8060] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 263667538 STATE OF INCORPORATION: FL FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1301 CONCORD TERRACE CITY: SUNRISE STATE: FL ZIP: 33323 BUSINESS PHONE: 9543840175 MAIL ADDRESS: STREET 1: 1301 CONCORD TERRACE CITY: SUNRISE STATE: FL ZIP: 33323 FORMER COMPANY: FORMER CONFORMED NAME: MEDNAX, INC. DATE OF NAME CHANGE: 20090102 FORMER COMPANY: FORMER CONFORMED NAME: PEDIATRIX MEDICAL GROUP INC DATE OF NAME CHANGE: 19950801 4 1 ownership.xml 4 X0508 4 2024-08-09 0000893949 Pediatrix Medical Group, Inc. MD 0001468881 Richards C Marc 1301 CONCORD TERRACE SUNRISE FL 33323 false true false false EVP, Chief Financial Officer false Common Stock 2024-08-09 4 S false 32562 10.08 D 192785 D Common Stock 2024-08-12 4 S false 17438 10.08 D 175347 D The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions with prices randing from $10.01 to $10.23 for a weighted average sales price of $10.08. The reporting person undertakes to provide the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each seperate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions with prices ranging from $10.00 to $10.17 for a weighted average sales price of $10.08. The reporting person undertakes to provide the issuer, any security holder of the issuer or the staff of the Securiites and Exchange Commission upon request, full information regarding the number of shares sold at each seperate price within the range set forth in this footnote. /s/ Mary Ann E. Moore, Attorney-in-Fact 2024-08-13